Your session is about to expire
← Back to Search
MRI
Intervention for Aging (DASH Trial)
N/A
Waitlist Available
Research Sponsored by Northeastern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; 6-week
Awards & highlights
DASH Trial Summary
This trial will test whether a daily health messaging intervention delivered via smart phone can improve sedentary older adults' understanding of their daily activities and emotions, as measured by structural and functional brain imaging.
DASH Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline; 6-week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; 6-week
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Sedentary Behavior (Average Hour/Day)
Secondary outcome measures
Change in Moderate-to-Vigorous Physical Activity
DASH Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Brain MRI and Motivational Behavioral Intervention
Group II: Active controlActive Control1 Intervention
Brain MRI and Control Behavioral Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Motivational MRI and Behavioral Intervention
2020
N/A
~40
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,845 Total Patients Enrolled
160 Trials studying Aging
75,967 Patients Enrolled for Aging
Northeastern UniversityLead Sponsor
88 Previous Clinical Trials
61,270 Total Patients Enrolled
4 Trials studying Aging
437 Patients Enrolled for Aging
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You do not have any neurological diseases.You are currently struggling with alcohol or drug addiction.You must be able to speak English well.Your body mass index (BMI) should be between 20 and 40.You have a condition affecting your brain such as multiple sclerosis, Parkinson's disease, dementia, mild cognitive impairment, brain injury from a stroke or traumatic event.You are taking medications for mental health conditions such as depression, anxiety, ADHD, or psychosis.You have a medical condition that is not currently under control or stable.You have been diagnosed with a mental disorder such as major depression according to the DSM-V.You have a history of severe mental illness like schizophrenia, but not including general anxiety disorder or depression.
Research Study Groups:
This trial has the following groups:- Group 1: Active control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
New Jersey
Massachusetts
New York
How old are they?
18 - 65
What site did they apply to?
Northeastern University
What portion of applicants met pre-screening criteria?
Met criteria
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger